Physician profile
Flora Green
NPI 1982057345
$3,052.34
in general payments reported to CMS, 2019-2025
21 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $656 · 2023: $1,005 · 2024: $757 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $478.75 | 2021-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $358.83 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Axsome Therapeutics, INC. | $250.00 | 2023 | Auvelity |
| Abbvie INC. | $234.90 | 2023 | |
| Alexion Pharmaceuticals, INC. | $226.94 | 2022-2024 | |
| Inari Medical, INC. | $192.84 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kyowa Kirin, INC. | $164.27 | 2023-2024 | |
| Astellas Pharma Global Development | $129.60 | 2023 | Veozah |
| Lundbeck LLC | $125.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $124.26 | 2025 | |
| Edwards Lifesciences Corporation | $115.58 | 2024 | |
| Spinal Simplicity, LLC | $102.88 | 2023 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $102.60 | 2024 | Relistor |
| Medtronic, INC. | $92.73 | 2025 | Intellis Adaptivestim |
| Otsuka America Pharmaceutical, INC. | $85.32 | 2025 | Rexulti |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $82.07 | 2023 | Inspire |
| Ultragenyx Pharmaceutical INC. | $56.31 | 2022 | |
| Sk Life Science, INC. | $54.66 | 2023 | Xcopri |
| Insmed, INC. | $46.61 | 2025 | Arikayce |
| Abbott Laboratories | $16.73 | 2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Flora Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.